Derivative Instruments and Hedging Activities - Derivatives in Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Jan. 28, 2024	Jan. 29, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Unallocated net revenue	$ 6,707	$ 6,739
Cost of products sold	3,503	3,594
Research, development and engineering	754	771
Interest expense	59	59
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(2)	24
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0
Foreign exchange contracts | Sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	5	25
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0
Foreign exchange contracts | Cost of products sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(1)	2
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0
Foreign exchange contracts | Research, development and engineering
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(3)	0
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	0	0
Interest rate contracts | Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations	(3)	(3)
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations	$ 0	$ 0